No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
FDMT 4D Molecular Therapeutics
- 6.310
- +0.530+9.17%
Close Dec 20 16:00 ET
- 6.310
- 0.0000.00%
Post 20:01 ET
291.70MMarket Cap-2.21P/E (TTM)
6.370High5.740Low4.77MVolume5.800Open5.780Pre Close29.67MTurnover15.20%Turnover RatioLossP/E (Static)46.23MShares36.25052wk High0.53P/B197.83MFloat Cap5.58052wk Low--Dividend TTM31.35MShs Float55.110Historical High--Div YieldTTM10.90%Amplitude5.320Historical Low6.226Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday
BofA Securities Maintains 4D Molecular Therapeutics(FDMT.US) With Buy Rating, Cuts Target Price to $46
Express News | 4D Molecular Therapeutics Inc : BofA Global Research Cuts Price Objective to $46 From $79
Express News | 4Dmt Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in Iovs
We Think 4D Molecular Therapeutics (NASDAQ:FDMT) Can Afford To Drive Business Growth
4D Molecular Therapeutics, Inc. (FDMT): An Oversold Healthcare Stock to Invest In Now
Heat List
US
Overall
Symbol
Price
% Chg
No Data